BioScrip and Option Care Merge

BioScrip and Option Care Merge

BioScrip (NASDAQ: BIOS) and Option Care announced they are merging in perhaps the biggest home health deal of 2019 so far. Option Care provides home and alternate treatment site infusion services and is owned by Madison Dearborn Partners, LLC (MDP) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA). BioScrip offers infusion and home care management solutions, and as one of the largest nationwide providers, it services nearly 70 service locations nationwide. It partners with physicians, hospital systems,  and skilled nursing facilities to provide patients access to post-acute care services. BioScrip has made a few significant acquisitions itself over the past few years worth noting. It... Read More »

Physician Medical Group Sector Heats Up

Ten months into the year, and only two healthcare sectors have posted gains compared with 2015 totals. On the technology side, it’s eHealth, where deal volume is up 10% through the end of October, to 139 transactions. On the services side, it’s Physician Medical Groups. Deal volume now stands at 102 transactions, a 13% increase over last year’s 90 deals. (See chart below.)   The Medicare Access and CHIP Reauthorization Act (MACRA) is one factor behind the increase in physician practice acquisitions. Although the Centers for Medicare and Medicaid Services eased some rules regarding data reporting periods, timing and payment options, the law still calls for smaller practices to have... Read More »

Stryker’s Minimally Invasive Acquisitions

For a company that has targeted minimally invasive surgical products of late, Stryker Corporation (NYSE: SYK) has been highly visible in the acquisition arena this year. It started in February 2016. That month, the medical device giant announced three deals, totaling $2.03 billion. In April, three more acquisitions were announced, with only one disclosed price of $40.6 million. Halfway through September, the company has made two more acquisitions, for undisclosed prices. For those keeping score, that’s eight deals for approximately $4.1 billion. Stryker’s most recent deals have targeted Ivy Sports Medicine, LLC for its minimally invasive meniscal repair platform, and Restore... Read More »

Another Billion-Dollar Stryker Deal

It’s been one-a-week for Stryker Corporation (NYSE: SYK). The medical device maker announced two deals in February, including one for $2.77 billion. That was for Madison Dearborn Partners’ portfolio company, Sage Products LLC, which makes and distributes disposable products aimed at reducing hospital-acquired infections, primarily in the ICU and Med/Surg unit. The third week in February brought another big announcement, the acquisition of Physio-Control International, Inc. for nearly $1.3 billion, from Bain Capital. Physio-Control makes and markets monitors, defibrillators and CPR-assist devices, as well as data management and support services. This acquisition complements... Read More »

Stryker Strikes Two Deals in Two Weeks

Medical device maker Stryker Corporation (NYSE: SYK) announced its second deal in two weeks, buying the neurosurgery tools portfolio of Synergetics USA Inc. for an undisclosed sum. The portfolio consists of Synergetics’  Malis generator, Spetzler Malis disposable forceps, and Stryker’s existing Sonopet tips and RF generator. The products will complement Stryker’s neuro, spine and ear-nose-throat business, as well as expand its neurosurgical offerings. The first deal, announced on February 1, was Stryker’s nearly $2.8 billion acquisition of Sage Products, LLC, a portfolio company of Madison Dearborn Partners, LLC. Sage develops, manufactures and distributes... Read More »